Market Trends– category –
-
Biopharma’s Evolving Blueprint: AGC Biologics Expands Global Capacity, Enzene Drives Continuous Manufacturing Adoption
Pharma Manufacturing USA Overview This news digest highlights several pivotal developments in the biopharmaceutical manufacturing sector, showcasing an industry-wide acceleration towards enhanced capacity and technological innovation. Ke... -
Biomanufacturing Reorients: Geopolitical Forces Drive Sourcing to Qualified, Regional Capacity, with Cellares Pioneering IDMO Smart Factories
Pharma's Almanac USA Overview Geopolitical forces are profoundly reshaping biomanufacturing procurement, driving a surge in demand for 'qualified capacity' – providers with specialized expertise and robust regulatory compliance. This shi... -
Cell Therapy Consumables Market Set for $7.53 Billion Surge by 2032, Fueled by Automation and Closed Systems
Credence Research India Overview A new report from Credence Research projects the global cell therapy consumables market will reach $7.53 billion by 2032. This significant growth is primarily driven by the expanding adoption of advanced ... -
CDMOs Accelerate GLP-1 Manufacturing, Outpacing Traditional Facility Builds to Meet Soaring Demand
Pharma Advancement USA Overview Contract Development and Manufacturing Organizations (CDMOs) are rapidly scaling their manufacturing capabilities for GLP-1 receptor agonists, providing quicker solutions than ground-up facility constructi... -
July 2026 Pharma M&A Review Highlights Manufacturing Partnerships and AI Innovation as Key Trends, Featuring Major Investments by Lonza, AGC Biologics, and Evonik
Biospectrum Jobs India Overview A July 2026 review of pharmaceutical M&A activities identifies manufacturing partnerships and AI innovation as critical emerging trends. Key players like Lonza expanded biopharmaceutical alliances, AGC... -
AI-Powered Biologics: AstraZeneca and CSPC Forge Strategic Manufacturing Alliance in China
Fierce Pharma China Overview AstraZeneca and CSPC Pharmaceutical have formed a joint venture to establish a new biopharmaceutical manufacturing facility in Shijiazhuang, China. CSPC will contribute AI-driven GMP systems and manufacturing... -
Gene Therapy’s Backbone: Oxford Biomedica Acquires ABL Europe, Driving Consolidation in Viral Vector Manufacturing
Industry News UK Overview The viral vector manufacturing market, crucial for gene therapy commercialization, is experiencing accelerated consolidation driven by M&A, exemplified by Oxford Biomedica's acquisition of ABL Europe. This s... -
APAC’s Biomanufacturing Ascent: Australia Pioneers Viral Vector Production for Gene Therapies
Industry Publication Australia Overview The Asia-Pacific (APAC) region is rapidly accelerating its specialized manufacturing capabilities for high-value modalities like viral vectors and cell therapies, moving beyond traditional API prod... -
Enzene Unveils ‘NeX’ Partnership Model to Globalize Biologics Production via Continuous Manufacturing
PharmaSource India Overview Enzene has launched 'NeX,' an end-to-end partnership model designed to establish regional biopharmaceutical manufacturing capabilities globally. Leveraging its fully connected continuous manufacturing platform... -
Gene Therapy’s Production Puzzle: Why AAV Outscales Lentiviral Vectors in Large-Scale Manufacturing
Industry Analysis USA Overview A recent analysis comparing AAV and lentiviral vector manufacturing platforms, both produced via transient transfection of HEK293 cells, reveals critical downstream manufacturing distinctions. AAV's stable ...
